NCT03180281 Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell Status UNKNOWN Phase NA
NCT03176056 The Effectiveness of Low Carbohydrate Diet in Reducing Polypharmacy for Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT03170544 Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) Status COMPLETED Phase PHASE1
NCT03169959 A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration. Status COMPLETED Phase PHASE1
NCT03167918 Lung Function in Patients With Early Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2/PHASE3
NCT03167684 Effect of Oral Appliance Therapy on Glucose Levels in Patients With T2DM and OSA: A Pilot Trial Status UNKNOWN Phase NA
NCT03164785 Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease Status COMPLETED Phase PHASE2/PHASE3
NCT03164538 A Psychological-behavioral Intervention to Increase Activity in Type 2 Diabetes Status COMPLETED Phase NA
NCT03159299 Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City Status COMPLETED Phase NA
NCT03159052 Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes Status UNKNOWN Phase PHASE3
NCT03156985 Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China Status COMPLETED Phase N/A
NCT03152994 The Early Predictors for Developing Type 2 Diabetes Mellitus in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT03138356 Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03131687 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT03130426 Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi Status COMPLETED Phase PHASE3
NCT03127696 Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM Status COMPLETED Phase NA
NCT03120299 The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN) Status COMPLETED Phase PHASE4
NCT03118713 A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria Status TERMINATED Phase PHASE4
NCT03115112 Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects Status COMPLETED Phase PHASE3